A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients

1220.48.0004 Boehringer Ingelheim Investigational Site, Birmingham

1220.48.0091 Boehringer Ingelheim Investigational Site, North Little Rock

1220.48.0011 Boehringer Ingelheim Investigational Site, Los Angeles

1220.48.0018 Boehringer Ingelheim Investigational Site, Oceanside

1220.48.0078 Boehringer Ingelheim Investigational Site, Fort Lauderdale

1220.48.0095 Boehringer Ingelheim Investigational Site, Palm Harbor

1220.48.0039 Boehringer Ingelheim Investigational Site, Columbus

1220.48.0013 Boehringer Ingelheim Investigational Site, Chicago

1220.48.0087 Boehringer Ingelheim Investigational Site, Baton Rouge

1220.48.0027 Boehringer Ingelheim Investigational Site, Framingham

1220.48.0065 Boehringer Ingelheim Investigational Site, Springfield

1220.48.0023 Boehringer Ingelheim Investigational Site, Tupelo

1220.48.0066 Boehringer Ingelheim Investigational Site, Neptune City

1220.48.0012 Boehringer Ingelheim Investigational Site, New York

1220.48.0058 Boehringer Ingelheim Investigational Site, Portland

1220.48.0063 Boehringer Ingelheim Investigational Site, Arlington

1220.48.0029 Boehringer Ingelheim Investigational Site, Austin

1220.48.0017 Boehringer Ingelheim Investigational Site, Dallas

1220.48.0071 Boehringer Ingelheim Investigational Site, Dallas

1220.48.0081 Boehringer Ingelheim Investigational Site, Forth Worth

1220.48.4301 Boehringer Ingelheim Investigational Site, Vienna

1220.48.4302 Boehringer Ingelheim Investigational Site, Vienna

1220.48.3201 Boehringer Ingelheim Investigational Site, Brussels

1220.48.3204 Boehringer Ingelheim Investigational Site, Edegem

1220.48.3203 Boehringer Ingelheim Investigational Site, Liège

1220.48.1012 Boehringer Ingelheim Investigational Site, Edmonton

1220.48.1003 Boehringer Ingelheim Investigational Site, Vancouver

1220.48.1016 Boehringer Ingelheim Investigational Site, Vancouver

1220.48.1007 Boehringer Ingelheim Investigational Site, Victoria

1220.48.1009 Boehringer Ingelheim Investigational Site, Winnipeg

1220.48.1005 Boehringer Ingelheim Investigational Site, Toronto

1220.48.1006 Boehringer Ingelheim Investigational Site, Toronto

1220.48.3301 Boehringer Ingelheim Investigational Site, Clichy

1220.48.3311 Boehringer Ingelheim Investigational Site, Lille

1220.48.3303 Boehringer Ingelheim Investigational Site, Marseille

1220.48.3304 Boehringer Ingelheim Investigational Site, Montpellier

1220.48.3305 Boehringer Ingelheim Investigational Site, Nice

1220.48.3316 Boehringer Ingelheim Investigational Site, Pessac

1220.48.3312 Boehringer Ingelheim Investigational Site, Saint-Laurent-du-Var

1220.48.4902 Boehringer Ingelheim Investigational Site, Berlin

1220.48.4904 Boehringer Ingelheim Investigational Site, Berlin

1220.48.4913 Boehringer Ingelheim Investigational Site, Dortmund

1220.48.4906 Boehringer Ingelheim Investigational Site, Düsseldorf

1220.48.4901 Boehringer Ingelheim Investigational Site, Frankfurt am Main

1220.48.4908 Boehringer Ingelheim Investigational Site, Hamburg

1220.48.4914 Boehringer Ingelheim Investigational Site, Kiel

1220.48.4911 Boehringer Ingelheim Investigational Site, Mainz

1220.48.4905 Boehringer Ingelheim Investigational Site, München

1220.48.8106 Boehringer Ingelheim Investigational Site, Chiba, Chiba

1220.48.8117 Boehringer Ingelheim Investigational Site, Kita-gun, Kagawa

1220.48.8116 Boehringer Ingelheim Investigational Site, Kurashiki, Okayama

1220.48.8118 Boehringer Ingelheim Investigational Site, Kurume, Fukuoka

1220.48.8113 Boehringer Ingelheim Investigational Site, Nagoya, Aichi

1220.48.8114 Boehringer Ingelheim Investigational Site, Nishinomiya, Hyogo

1220.48.8119 Boehringer Ingelheim Investigational Site, Omura, Nagasaki

1220.48.8121 Boehringer Ingelheim Investigational Site, Osaka, Osaka

1220.48.3503 Boehringer Ingelheim Investigational Site, Aveiro

1220.48.3509 Boehringer Ingelheim Investigational Site, Barreiro

1220.48.3501 Boehringer Ingelheim Investigational Site, Lisbon

1220.48.3502 Boehringer Ingelheim Investigational Site, Porto

1220.48.4002 Boehringer Ingelheim Investigational Site, Bucharest

1220.48.7001 Boehringer Ingelheim Investigational Site, Moscow

1220.48.7004 Boehringer Ingelheim Investigational Site, Moscow

1220.48.8204 Boehringer Ingelheim Investigational Site, Pusan

1220.48.8205 Boehringer Ingelheim Investigational Site, Pusan

1220.48.8206 Boehringer Ingelheim Investigational Site, Seoul

1220.48.8207 Boehringer Ingelheim Investigational Site, Seoul

1220.48.8201 Boehringer Ingelheim Investigational Site, Yangsan

1220.48.3406 Boehringer Ingelheim Investigational Site, A Coruña

1220.48.3402 Boehringer Ingelheim Investigational Site, Barcelona

1220.48.3404 Boehringer Ingelheim Investigational Site, Barcelona

1220.48.3411 Boehringer Ingelheim Investigational Site, Barcelona

1220.48.3412 Boehringer Ingelheim Investigational Site, Barcelona

1220.48.3405 Boehringer Ingelheim Investigational Site, Madrid

1220.48.3409 Boehringer Ingelheim Investigational Site, Madrid

1220.48.3410 Boehringer Ingelheim Investigational Site, Majadahonda-Madrid

1220.48.3403 Boehringer Ingelheim Investigational Site, Seville

1220.48.3401 Boehringer Ingelheim Investigational Site, Valencia

1220.48.4106 Boehringer Ingelheim Investigational Site, Bern

1220.48.8802 China Medical University Hospital, Taichung

1220.48.4405 Boehringer Ingelheim Investigational Site, Bristol

1220.48.4409 Boehringer Ingelheim Investigational Site, London

1220.48.4401 Boehringer Ingelheim Investigational Site, Manchester

1220.48.4408 Boehringer Ingelheim Investigational Site, Nottingham

1220.48.4407 Boehringer Ingelheim Investigational Site, Oxford

1220.48.4403 Boehringer Ingelheim Investigational Site, Southampton

1220.48.4404 Boehringer Ingelheim Investigational Site, Tooting, London